Page last updated: 2024-10-18

glyceraldehyde and Colorectal Neoplasms

glyceraldehyde has been researched along with Colorectal Neoplasms in 3 studies

Glyceraldehyde: An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.
glyceraldehyde : An aldotriose comprising propanal having hydroxy groups at the 2- and 3-positions. It plays role in the formation of advanced glycation end-products (AGEs), a deleterious accompaniment to ageing.
aldose : Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n >= 2) and their intramolecular hemiacetals.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties."8.31Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. ( Aglago, E; Amiano, P; Baker, JR; Colorado-Yohar, SM; Crous-Bou, M; de Magistris, MS; Derksen, JWG; Eriksen, AK; Fedirko, V; Freisling, H; Gram, IT; Guevara, M; Gunter, M; Harlid, S; Heath, AK; Hyogo, H; Jenab, M; Johansson, I; Kaaks, R; Katzke, V; Laouali, N; Mao, Z; Palli, D; Perez-Cornago, A; Quirós, JR; Rothwell, J; Sacerdote, C; Sánchez, MJ; Sandanger, TM; Schulze, MB; Severi, G; Sieri, S; Skeie, G; Takeuchi, M; Tjønneland, A; Tumino, R; Weiderpass, E, 2023)
"Microbial dysbiosis is a colorectal cancer (CRC) hallmark and contributes to inflammation, tumor growth, and therapy response."5.72Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance. ( Andren, A; Bell, HN; Das, NK; Fearon, ER; Goyert, J; Gygi, SP; Huang, W; Kerk, SA; Kuljanin, M; Lyssiotis, CA; Mancias, JD; Miller, SL; Rebernick, RJ; Shah, YM; Singhal, R; Solanki, S; Todd, PK, 2022)
"A large proportion of colorectal cancers are thought to be associated with unhealthy dietary and lifestyle exposures, particularly energy excess, obesity, hyperinsulinemia, and hyperglycemia."5.42The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk. ( Aleksandrova, K; Ardanaz, E; Bastide, N; Boeing, H; Boutron-Ruault, MC; Bradbury, KE; Bruce, WR; Bueno-de-Mesquita, HB; Carbonnel, F; Chayama, K; Cross, AJ; Dorronsoro, M; Ferrari, P; Freisling, H; Gavrila, D; Gunter, MJ; Hyogo, H; Jakszyn, P; Jenab, M; Kaaks, R; Khaw, KT; Kong, SY; Kühn, T; Lagiou, P; Masala, G; McKeown-Eyssen, G; Naccarati, A; Nyström, H; O'Brien, PJ; Olsen, A; Overvad, K; Pala, V; Peeters, PH; Quirós, JR; Riboli, E; Romieu, I; Rutegård, M; Sánchez, MJ; Santucci De Magistris, M; Stavropoulou, F; Takeuchi, M; Tjønneland, A; Trichopoulou, A; Tumino, R; Vasilopoulou, E; Wareham, NJ; Weiderpass, E; Yamagishi, S, 2015)
"Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties."4.31Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. ( Aglago, E; Amiano, P; Baker, JR; Colorado-Yohar, SM; Crous-Bou, M; de Magistris, MS; Derksen, JWG; Eriksen, AK; Fedirko, V; Freisling, H; Gram, IT; Guevara, M; Gunter, M; Harlid, S; Heath, AK; Hyogo, H; Jenab, M; Johansson, I; Kaaks, R; Katzke, V; Laouali, N; Mao, Z; Palli, D; Perez-Cornago, A; Quirós, JR; Rothwell, J; Sacerdote, C; Sánchez, MJ; Sandanger, TM; Schulze, MB; Severi, G; Sieri, S; Skeie, G; Takeuchi, M; Tjønneland, A; Tumino, R; Weiderpass, E, 2023)
"Microbial dysbiosis is a colorectal cancer (CRC) hallmark and contributes to inflammation, tumor growth, and therapy response."1.72Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance. ( Andren, A; Bell, HN; Das, NK; Fearon, ER; Goyert, J; Gygi, SP; Huang, W; Kerk, SA; Kuljanin, M; Lyssiotis, CA; Mancias, JD; Miller, SL; Rebernick, RJ; Shah, YM; Singhal, R; Solanki, S; Todd, PK, 2022)
"A large proportion of colorectal cancers are thought to be associated with unhealthy dietary and lifestyle exposures, particularly energy excess, obesity, hyperinsulinemia, and hyperglycemia."1.42The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk. ( Aleksandrova, K; Ardanaz, E; Bastide, N; Boeing, H; Boutron-Ruault, MC; Bradbury, KE; Bruce, WR; Bueno-de-Mesquita, HB; Carbonnel, F; Chayama, K; Cross, AJ; Dorronsoro, M; Ferrari, P; Freisling, H; Gavrila, D; Gunter, MJ; Hyogo, H; Jakszyn, P; Jenab, M; Kaaks, R; Khaw, KT; Kong, SY; Kühn, T; Lagiou, P; Masala, G; McKeown-Eyssen, G; Naccarati, A; Nyström, H; O'Brien, PJ; Olsen, A; Overvad, K; Pala, V; Peeters, PH; Quirós, JR; Riboli, E; Romieu, I; Rutegård, M; Sánchez, MJ; Santucci De Magistris, M; Stavropoulou, F; Takeuchi, M; Tjønneland, A; Trichopoulou, A; Tumino, R; Vasilopoulou, E; Wareham, NJ; Weiderpass, E; Yamagishi, S, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bell, HN1
Rebernick, RJ1
Goyert, J1
Singhal, R1
Kuljanin, M1
Kerk, SA1
Huang, W1
Das, NK1
Andren, A1
Solanki, S1
Miller, SL1
Todd, PK1
Fearon, ER1
Lyssiotis, CA1
Gygi, SP1
Mancias, JD1
Shah, YM1
Mao, Z1
Baker, JR1
Takeuchi, M2
Hyogo, H2
Tjønneland, A2
Eriksen, AK1
Severi, G1
Rothwell, J1
Laouali, N1
Katzke, V1
Kaaks, R2
Schulze, MB1
Palli, D1
Sieri, S1
de Magistris, MS1
Tumino, R2
Sacerdote, C1
Derksen, JWG1
Gram, IT1
Skeie, G1
Sandanger, TM1
Quirós, JR2
Crous-Bou, M1
Sánchez, MJ2
Amiano, P1
Colorado-Yohar, SM1
Guevara, M1
Harlid, S1
Johansson, I1
Perez-Cornago, A1
Freisling, H2
Gunter, M1
Weiderpass, E2
Heath, AK1
Aglago, E1
Jenab, M2
Fedirko, V1
Kong, SY1
McKeown-Eyssen, G1
Yamagishi, S1
Chayama, K1
O'Brien, PJ1
Ferrari, P1
Overvad, K1
Olsen, A1
Boutron-Ruault, MC1
Bastide, N1
Carbonnel, F1
Kühn, T1
Boeing, H1
Aleksandrova, K1
Trichopoulou, A1
Lagiou, P1
Vasilopoulou, E1
Masala, G1
Pala, V1
Santucci De Magistris, M1
Naccarati, A1
Bueno-de-Mesquita, HB1
Peeters, PH1
Jakszyn, P1
Dorronsoro, M1
Gavrila, D1
Ardanaz, E1
Rutegård, M1
Nyström, H1
Wareham, NJ1
Khaw, KT1
Bradbury, KE1
Romieu, I1
Stavropoulou, F1
Gunter, MJ1
Cross, AJ1
Riboli, E1
Bruce, WR1

Other Studies

3 other studies available for glyceraldehyde and Colorectal Neoplasms

ArticleYear
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
    Cancer cell, 2022, 02-14, Volume: 40, Issue:2

    Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Ani

2022
Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients.
    International journal of cancer, 2023, 06-01, Volume: 152, Issue:11

    Topics: Body Mass Index; Colorectal Neoplasms; Glycation End Products, Advanced; Glyceraldehyde; Humans; Pro

2023
The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015, Volume: 24, Issue:12

    Topics: Case-Control Studies; Cohort Studies; Colorectal Neoplasms; Europe; Female; Glycation End Products,

2015